ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638842 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638842; 2) Community: the network communities that were significantly associated with the response to NSC 638842; 3) Molecule: the relationships between components within communities and NSC 638842; 4) MDR: the compounds that were significantly associated with the NSC 638842.

NSC Compound Enrichment Correlation
NSC 741237 Null 0.0137891122538509 0.07997021
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0137891122538509 -0.10180346
NSC 762611 Null 0.0137891122538509 -0.042652988
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0137891122538509 0.36901869
NSC 105014 Cladribine 0.013789112253851 -0.02184146
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.013789112253851 0.13791082
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.013789112253851 0.088014939
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.013789112253851 -0.046155191
NSC 638624 Null 0.013789112253851 0.0016641294
NSC 63878 Cytarabine Hydrochloride AZ 0.013789112253851 0.10851469
Total:58  Current:23    [First] [Prev] [Next] [Last]